Laboratory Reagents
•45 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (45)
%
| Company | Market Cap | Price |
|---|---|---|
|
Laboratory Reagents are used in molecular biology and analytical workflows within Danaher’s diagnostics/bioprocessing ecosystems.
|
$144.89B |
$202.46
-1.20%
|
|
BD sells laboratory reagents used in molecular biology and analytical workflows.
|
$53.47B |
$186.56
-1.50%
|
|
IDEXX supplies laboratory reagents and test consumables for its diagnostic platforms (e.g., VetLab consumables), a significant revenue source.
|
$49.55B |
$616.15
-2.00%
|
|
The company sells laboratory reagents and consumables to support instrument-based workflows and PFAS testing.
|
$40.00B |
$140.11
-0.12%
|
|
The core business includes high-throughput consumables and sequencing reagents used in genomic workflows (e.g., SBS chemistry reagents).
|
$14.86B |
$93.86
-2.73%
|
|
QIAGEN manufactures laboratory reagents used in molecular biology and diagnostics.
|
$10.49B |
$46.85
-1.10%
|
|
Laboratory reagents used in molecular biology and analytical workflows (consumables revenue).
|
$9.91B |
$84.06
+0.79%
|
|
Avantor directly provides laboratory reagents and GMP-grade chemicals used across R&D and manufacturing workflows.
|
$9.13B |
$13.40
-1.83%
|
|
Bio-Techne sells high-purity laboratory reagents (proteins, antibodies, and related reagents) as a foundational product category.
|
$8.72B |
$55.63
+6.51%
|
|
Bio-Rad directly sells laboratory reagents and consumables used in molecular biology and diagnostics.
|
$8.10B |
$284.88
|
|
Bio-Rad's reagents and kits used as research essentials align with laboratory reagents.
|
$7.73B |
$284.07
-0.50%
|
|
Retrogenix cell microarray technology and related screening capabilities position CRL as a provider of laboratory reagents/platforms for screening and toxicity assays.
|
$7.38B |
$146.07
-2.26%
|
|
Grifols provides laboratory reagents used in diagnostics (e.g., Gel Cards, RBC reagents) as part of its diagnostics offerings.
|
$6.41B |
$9.32
-1.58%
|
|
Bruker sells laboratory reagents and metabolomics kits (Biocrates) used in analytical testing.
|
$5.35B |
$35.28
-2.54%
|
|
DNA oligos, gene fragments and related enzymes are sold as laboratory reagents to researchers.
|
$1.87B |
$31.19
-6.39%
|
|
QuidelOrtho markets and sells laboratory reagents used in diagnostic workflows.
|
$1.78B |
$26.37
-6.56%
|
|
TXG sells reagents and kits used in single-cell/spatial assays as part of consumables, i.e., laboratory reagents.
|
$1.55B |
$12.39
+5.45%
|
|
Consumables & reagents used in genomic workflows are part of Azenta's core product offerings within SMS.
|
$1.41B |
$30.73
-3.30%
|
|
Neogen produces culture media and laboratory reagents that underpin its diagnostic test kits and plating systems.
|
$1.31B |
$6.04
-12.21%
|
|
CryoStor and HypoThermosol are reagent-like biopreservation media sold for cell preservation in CGT workflows.
|
$1.17B |
$25.51
+3.74%
|
|
Company directly manufactures and sells Laboratory Reagents including nucleic acid inputs (mRNA, oligos), enzymes, and BST kit components used in nucleic acid production and biologics safety testing.
|
$812.36M |
$3.19
-3.92%
|
|
Reagents offering includes proprietary biological assets (e.g., cell-free protein synthesis kit).
|
$791.35M |
$13.52
-12.04%
|
|
FDA-registered cGMP pharmaceutical manufacturing facility producing PBS repository reagents for labs.
|
$508.00M |
$6.35
-4.08%
|
|
SomaScan platform uses proprietary SOMAmer lab reagents; LAB directly manufactures/sells these lab reagents.
|
$497.57M |
$1.31
-5.07%
|
|
Cytek is growing its reagents business (reagents for flow cytometry) alongside its instrument platforms.
|
$462.00M |
$3.67
+1.52%
|
|
PacBio provides consumables and reagents (e.g., SMRT Cells, chemistry) that are used with its sequencing instruments.
|
$426.12M |
$1.42
-8.97%
|
|
They provide laboratory reagents and sequencing kits (e.g., Version 4 Sequencing Kit, Library Preparation Kit) used with their platforms.
|
$306.44M |
$1.67
-7.73%
|
|
Teknova's core business is manufacturing and selling laboratory reagents (catalog and custom) for RUO and GMP clinical applications.
|
$301.41M |
$5.64
-8.89%
|
|
Quanterix sells assay reagents and consumables for Simoa assays and provides Accelerator Lab testing services.
|
$219.00M |
$5.64
-6.00%
|
|
Consumables/reagents used with the Growth Direct system contribute to recurring revenue in laboratory workflows.
|
$167.56M |
$3.79
+7.37%
|
|
Engineered nanoparticle reagents used in the Proteograph Product Suite.
|
$134.22M |
$2.28
+2.70%
|
|
IKT is developing a pY39 antibody biomarker for target engagement, representing Laboratory Reagents.
|
$120.43M |
$1.62
|
|
The company manufactures reagents/consumables for its diagnostic assays as part of its kit-based products.
|
$111.25M |
$3.89
+2.37%
|
|
Nautilus markets proprietary laboratory reagents, including multi-affinity probes and related consumables used with the platform.
|
$107.30M |
$0.85
-6.53%
|
|
Molecular biology reagents and kits used in ctDNA/NGS workflows align with Laboratory Reagents.
|
$86.30M |
$8.36
-4.46%
|
|
Akoya produces molecular barcode antibodies and related reagents (PhenoCode) for ultrahigh-plex panels.
|
$64.26M |
$1.29
|
|
Life Sciences segment sells laboratory reagents and related biological materials (antibodies, reagents).
|
$42.72M |
$36.01
|
|
Enzo Life Sciences produces and sells laboratory reagents including antibodies, genomic probes, assays, biochemicals and proteins used as essential research and drug development tools.
|
$36.59M |
$0.70
|
|
Directly produces laboratory reagents and enzymes (e.g., RNase-free DNase1, RNase inhibitors, polymerases, and related kits).
|
$31.60M |
$1.05
-7.08%
|
|
IV-Cell culture media and related laboratory reagents are direct product offerings.
|
$28.79M |
$19.04
-7.65%
|
|
The company derives consumables revenue (biochips) used with its systems, which aligns with Laboratory Reagents.
|
$18.55M |
$0.42
-5.64%
|
|
IVF media production is a laboratory media/reagent product used in assisted reproduction, mapped to Laboratory Reagents.
|
$17.28M |
$0.96
-12.73%
|
|
The platform relies on proprietary oligonucleotide primers and lab reagents (Co-Primers), implying direct production of laboratory reagents.
|
$12.92M |
$0.38
+3.59%
|
|
Laboratory reagents (columns, buffers) used in HbA1c testing and related assays.
|
$8.05M |
$1.05
-3.67%
|
|
NDPD Pharma supplies specialized equipment and carbohydrate molecules, aligning with Laboratory Reagents.
|
$6.67M |
$0.07
|
Loading industry metrics...
Loading comparison data...
